4th Inhalation & Respiratory Drug Delivery Online Conference 2021

25th-26th of February, 15:00 CET

BigMarker platform

ABOUT CONFERENCE

We are delighted to invite you 4th Inhalation & Respiratory Drug Delivery Online Conference that will be held Online on 25-26th of February 2021 at 15:00 CET on BigMarker.

4th Inhalation & Respiratory Drug Delivery Online Conference will give you a unique opportunity to discuss last trends and innovations in inhalation technologies, the new challenges and approaches of the inhaler models on the market. The agenda also features digital future of effective respiratory devices, key studies on the latest trends in inhalation devices and personalized treatments with large and small molecules for different respiratory diseases.

Presentations will also be focused on the topics, such as: pMDI, APIs/Drug and the future potential for effective OINDPs treatment lung infection. The event is modeled for the senior manager representatives, experts and main decision makers who are interested to be acquainted with the latest approaches and inventions of the respiratory drug products delivery field.

Exhibitors | Sponsors | Media Partners

Break Add sponsor

Q&A sponsor

Virtual Tour Sponsor

Workshop PARTNER

exhibition partner

media partners

Key points

  • Micronization: of The API/Drug
  • Environmental Friendliness of MDI & DPI Inhaler
  • Regulation Status Of Drug Delivery Devices After Brexit
  • Effective OINDPs Treatment Lung Infection
  • Design & Functionality in DPI/MDI
  • Last Trends & Innovations
  • Smart Inhalers in RDD Market

Who should attend

CEOs / VPs / Drug Developers / Academics and Researchers /

 CROs / Scientists and Medical Doctors of:

  • Respiratory Drug Development
  • Generics & Respiratory
  • Inhalation Drug Delivery Technologies
  • Device Development and Engineering
  • Respiratory Pharmacology
  • Medical Devices & Injectors
  • Inhalation Device Development
  • Inhaled Formulation Science
  • Inhalation Product Development
  • Respiratory Regulations
  • Generics & Respiratory
  • Inhalation Process Development
  • Respiratory Medicine
  • Inhalation Drug Delivery
  • E-Health
  • Inhaled Dosage Forms
  • Outsourcing
  • Process Development
  • Respiratory Pharmacology
  • Device Engineering
  • Drug Delivery Innovation
  • Inhalation Devices
  • Metered Dose Inhaler Development
  • Medical Marketing
  • Respiratory R&D
  • Particle Characterisation
  • Business Development
  • New Delivery Technologies
  • Connective Health
  • Respiratory Regulations
  • Pulmonary Disease
  • Inhalation
  • Scientific Research

ONLINE CONFERENCE INCLUDES

  • 7+ different topics
  • panel discussion
  • networking with business professionals and industry experts
  • additional materials
If you would like to participate, kindly book your spot. The seats are limited.
Broadcast Link will be provided via email post registration.

Event Schedule

15:00 – 15:10 CET

Welcome and opening remarks from the moderator

15:10 – 15:35 CET

Developing Advanced Characterization Tools to Facilitate Alternative Bioequivalence Strategies for ONIDPs + Q&A

15:35 – 15:55 CET

New Opportunities In Patient Treatment With Connected Nebulizer Platforms & Monitoring Devices In Holistic Therapy Eco Systems + Q&A

15:55 – 16:00 CET

BREAK

16:00 – 16:25 CET

Understanding Inhalation Pre-clinical Development + Q&A

16:25 – 16:50 CET

Quality by Design for API Development as Success for Respiratory + Q&A

16:55 – 17:20 CET

The Next Generation Drug Carrier for Inhaled Formulations + Q&A

17:20 – 17:45 CET

Evolutions of single-dose reusable Dry Powder Inhalers Steps in direction of patient centricity and environmental sustainability.

17:450 – 17:55 CET

CLOSING SESSION REMARKS

15:00 – 15:10 CET

Welcome and opening remarks from the moderator

15:10 – 15:35 CET

Phase Appropriate Combination Product Development & Life Cycle Management + Q&A

15:35 – 15:55 CET

Strategies to Accelerate Robust Dry PowderInhaler Development: Utilizing a Multivariate Approach to Understand the Role of Excipient Variation + Q&A

15:55 – 16:00 CET

BREAK

16:00 – 16:25 CET

Simplifying the Manufacturing Process for HFC 152a and Other Propellants + Q&A

16:25 – 16:50 CET

Novel Approaches for Systemic Drug Delivery via the Lungs + Q&A

16:55 – 17:20 CET

Trends and Innovations in the Field of Micronization of Inhalation Products and HPAPIs + Q&A

17:20 – 17:30 CET

CLOSING SESSION REMARKS

Dr. Jag Schur
CEO
Nanopharm, an Aptar Pharma Company
Ulf Krueger
CEO & Founder
Pulmotree Medical
Simon Moore
Global Lead of Inhalation Sciences and Engineering
Covance Laboratories
Enrico Bettetini
Senior Advisor Technology & Innovation
Oriento
Carsten Ehrhardt
Professor, Pharmaceutics & Biopharmaceutics
Trinity College
Ross Blezard
Product Application Specialist
DFE Pharma: Inhalation
Adam Feiler
Spiro Chief Technical Officer
Nanologica
Segolene Sarrailh
Inhalation & New Products Laboratory Manager
Aptar Pharma
James Leamon
Director, Biologics Device Development
Jazz Pharmaceuticals
Marco Franza
Sales & Business Development Director - Global Inhalation & Medical Devices
Berry Global Healthcare
Uwe Heidenreich
Business Development Manager
MUNIT SA

Contact Us

Kara Koz
Conference Producer
Tel.: +420 228 227 163
E-mail: kara.koz@bcf-events.com
Valerie Neumann
Marketing Manager
Tel.: +420 228 227 162
E-mail: valerie.neumann@bcfgroup.eu
Benazir Jursunbek
Operations Manager
Tel.: +420 228 227 164
E-mail: operations@bcf-events.com